Immatics Stock Discussion

$Immatics (IMTX.US)$ I checked their data on the SITC 2024 Annual meeting, their products named IMA203 showed very strong anti-tumor effect in melanoma.

$Immatics (IMTX.US)$ interesting offer and price tag, come back in 6 months, this float so big, PFE or someone liable to buy this out before that phase 3 ends, one of those you wake up to a surprise tickers but will be a while

$Immatics (IMTX.US)$ Been waiting for this to pop off based on its balance sheet!

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

$Immatics (IMTX.US)$ Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For ACTengine IMA203 TCR-T Monotherapy

Gapping up
News:
• $PyroGenesis Canada (PYR.US)$ +5.9% (announces that the negotiation for the land-based system to destroy PFAS contract has been suspended and discontinued)
• $Immatics (IMTX.US)$ +3.1% (announces a clinical data update for the IMA203)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX.US)$ +1.6% (rising with softness in futures)
• $Nevro (NVRO.US)$ +1.4% (comments on $UnitedHealth (UNH.US)$ medical coverage policy u...

Gapping up
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%,...

$Immatics (IMTX.US)$ over take. $25